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mitogen response was lower in H-HD than in healthy staff
and travellers (7.56 IU/mL vs 20.15 IU/mL, p < 0.001).
Conclusion: The IGRA test gives fewer indeterminate and
positive results than we expected from overseas reports.14th International Congress on Infectious Diseases (ICID) Abs
59.020
Fast identiﬁcation of Mycobacteria from positive Mb/Bact
bottles using a multiplex PCR
E.P.A. Bensi 1, C.E. Levy2, M. Ramos3,∗, P.C. Panunto1
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Background: The rapid identiﬁcation of mycobacteria
from culture-positive Mb/Bact bottles is an important clini-
cal issue. Furthermore, the availability of a non-expensive,
technically simple, and accurate method also would beneﬁt
mycobacterial laboratories in developing countries. In this
study, we aimed to develop an assay allowing the identiﬁ-
cation of the Mycobacterium tuberculosis complex (MTBC)
and other frequently isolated nontuberculous mycobacte-
ria (NTM) directly from positive Mb/Bact (Organon-Teknika)
bottles. A multiplex PCR focusing the hsp65 gene, and the
IS6110 was done and evaluated for its efﬁciency compared
to PRA identﬁcation, and PNB inhibition.
Methods: Mycobacterial strains were grown from clin-
ical samples and preserved in solid media (LJ). A panel
of 91 M. tuberculosis strains, and 26 Non-Tuberculous-
Mycobacteria were submitted to the following identiﬁcation
techniques: a) hsp65 gene ampliﬁcation followed by restric-
tion (PRA); b) p-Nitrobenzoic acid (PNB) growth inhibition
in liquid media (Mb/Bact); 3) Multiplex-PCR, using two sets
of primers: TB284/TB850 (IS6110 MTC spciﬁc primers), and
TB11/TB12 (65 kD antigen, Mycobacterium genus speciﬁc
primers). The mycobacteria was inactivated being heated at
80oC for 20min before DNA extraction. DNA was extracted
by the freezing and thawing method. 50l of the the super-
natant was used for ampliﬁcation. Identiﬁcation using hsp65
restriction was done according to international protocols
(Telenti et al, 1993), and considered the gold-standard. PNB
was added to liquid Mb/Bact bottles to a ﬁnal concentration
of 500g/ml. p-aminobenzoic acid, and the Mycobacterial
concentration was adjusted to the MacFarland 1 standard.
Results: The hsp65 restriction analysis identiﬁed all
Mycobacteria tested as: M.tuberculosis (61 strains),
M.avium, M.intracellulare, M.fortuitum, M.abscessus,
M.gordonae, M.szulgai. There was 100% agreement
between the tests performedts e311
Conclusion: A simple and inexpensive Multiplex-PCR as
escribed here, can readly distinguish among M. tuberculo-
is Complex strains, and Non-Tuberculous Mycobacteria.
oi:10.1016/j.ijid.2010.02.2176
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dentiﬁcation and treatment of latent tuberculosis infec-
ion in haemodialysis patients in New Zealand
. Verrall, M. Leikis, J. Hildreth, N. Raymond, T.
lackmore ∗
Capital and Coast DHB, Wellington, New Zealand
Background: International and local reports indicate that
uberculosis (TB) is a major issue in haemodialysis units
ecause of high rates, difﬁcult and late diagnosis, high
orbidity and mortality. Moreover, there is potential for
osocomial spread. The Mantoux test is unreliable in renal
isease, and appears to have lead to diagnostic nihilism
ith respect to latent TB infection (LTBI): no treatment of
TBI had been employed previously in our unit. The aims of
his study were to describe the epidemiology of active TB
ithin renal patients in the greater Wellington Region and
o develop a LTBI testing and treating algorithm using an
nterferongamma release assay (IGRA)
Methods: A ten year review of notiﬁcation data and clin-
cal records was used to identify and describe renal patients
ith active TB. All patients receiving hospital haemodialysis
H-HD) were screened using QUANTIFERON-Gold (Cellis-
is, Australia). Chest radiographs and clinical notes were
eviewed.
Results: Seven cases of active TB in H-HD patients were
dentiﬁed, approximating an incidence of 1.2/100 new dial-
sis patients. The overall annual incidence in New Zealand is
0.3/100,000. Six patients died (86% mortality), but mostly
his was not directly due to TB. All 65 H-HD patients were
creened for LTBI, 66% of whom were born outside NZ. Over-
ll 6 (9%) were positive and all but one were from overseas,
igh prevalence, countries. Three results were repeatedly
ndeterminate due to weak mitogen test results. The mean
e th In
T
o
e
p
r
I
i
h
r
d
5
T
t
G
J
i
P
(
t
s
B
o
v
3
f
ﬁ
t
p
d
G
w
m
T
t
Q
c
t
p
t
a
T
i
w
t
o
t
d
5
A
c
H
J
1
2
3
r
t
m
p
E
t
c
s
l
l
t
d
t
l
F
B
g
w
c
o
h
d
c
t
t
m
e
f
(
r
m
a
f
m
n
treatment with tuberculous drugs is effective, however the
early diagnosis is important to avoid clinical complication or
even association to malignance tumors.312 14
hose identiﬁed as having LTBI have all been commenced
n isoniazid therapy, apart from two patients who are not
xpected to survive long term. Treatment has been sim-
liﬁed by using directly observed therapy when patients
eceive dialysis. Those with negative and indeterminate
GRA results will be carefully followed, enabling further clin-
cal validation of the test. Most importantly, the IGRA test
as given greater conﬁdence to the renal unit staff and has
esulted in active management of LTBI in a high risk group.
oi:10.1016/j.ijid.2010.02.2177
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he role of a whole blood interferon- releasing assay for
he tracing of tuberculosis infection in bacilli Calmette
uerin vaccinated children
.-K. Chun ∗, E. Soon, H.M. Kim
Wonju Christian Hospital, Wonju, Korea, Republic of
Background: There are limited data about new
nterferon-/ releasing assay (IGRA) in pediatric ages.
aradoxically the screening of latent tuberculosis infection
LTBI) and the selection for isoniazid (INH) preventive
reatment have signiﬁcance in this age group. The high
peciﬁcity of IGRA has a merit in younger children under
CG effects. The aim of this study was to evaluate the role
f IGRA for the tracing of tuberculosis infection in BCG
accinated children.
Methods: For 24 months, between Jul. 1, 2007 and Jul.
1, 2009, data were collected from children who visited
or tuberculosis evaluation in Wonju Christian Hospital. The
rst group was composed of children who had close contact
o active tuberculosis patients, the second group was the
atients undergoing evaluations of tuberculosis with various
iseases. Tuberculin skin test (TST) and QuantiFERON®-TB
old In-Tube (QFT-G IT, Cellestis, Victoria, Australia) test
ere performed.
Results: A total of 70 children were evaluated and their
edian age was 5 year of age (range: 7 days — 16 years).
here were 24 patients who had history of contact to active
uberculosis but no symptoms. Among them, 5 patients were
FT-G IT positive and 10 patients were TST positive when the
utoff value is ≥5mm ( = 0.53), 5 patients were TST posi-
ive when the cutoff value is ≥10mm ( = 0.74). Fourty six
atients were evaluated to be ruled out tuberculosis infec-
ion and 16 patients were diagnosed as active tuberculosis
nd improved by antituberculosis medications. In 2nd group,
ST was positive in 9/16 (56.2%) and QFT-G IT was positive
n 11/16 (68.7%).
Conclusion: The results of IGRA seemed to be concordant
ith TST in pediatric age also in diagnosing LTBI and active
uberculosis. In BCG vaccinated children, using both meth-
ds would be useful for highly selective anti-tuberculosis
reatments.
oi:10.1016/j.ijid.2010.02.2178
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n unusual case of esophageal tuberculosis in immuno-
ompetent female patient
.F. Brito1,∗, R.F. Arbex1, C.M.S. Messina1, M.H. Froes2,
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Universidade Federal de Sao Paulo, Sao Paulo, Brazil
Instituto de Infectologia Emilio Ribas, Sao Paulo, Brazil
Instituto Clemente Ferreira, Sao Paulo, Brazil
Background: Esophageal tuberculosis is an extremely
are entity, totaling 3% of total patients with gastroin-
estinal tuberculosis (TB). Clinically these patients may be
istakenly diagnosed as esophageal carcinoma because dys-
hagia and weight loss are the more frequent symptoms.
sophageal TB involvement generally affects the middle-
hird of the esophagus around the carina. This usually is
aused by direct extension and spread from mediastinal
tructures, the previous mechanism of spreading the inocu-
ation of swallowed sputum, as well as by hematogenous or
ymphatic spread. The goal of this case presentation is order
o emphasize the importance of tuberculosis infection in the
ifferential diagnosis of gastrointestinal symptoms because
his form of TB can be successfully treated by antitubercu-
ous chemotherapy.
Methods: A 31-year-women was admitted to Clemente
erreira Institute, a reference center for tuberculosis in
razil, with complains of dysphagia and postprandial epi-
astria pain. It was associated with non-productive cough,
eight loss and weakness. She otherwise was in good health,
linical examination appeared normal and, she reported no
ther relevant symptoms. No TB contacted informed prior
istory of tuberculosis. She had no immunosuppressive con-
itions.
Results: The barium swallow ﬁlm revealed an extrinsic
ompression and erosion in the esophagus. She was submit-
ed to esophagogastroduodenoscopy showing large ulcers in
he esophagus, and the histopatological examination the
ucous biopsy showed ulcerative inﬂammation and pres-
nce of granulomatous inﬂammation, but a negative staining
or acidfast bacilli. She had a positive tuberculin skin test
13mm). Chest X-ray showing inﬁltration image at right hilar
egion. Tubercle bacilli were isolated on Lowenstein-Jensen
edium from sputum. Treatment with rifampin, isoniazid
nd pyrazinamide was initiated, having the patient shown
avorable clinical response during a follow-up period of 6
onths.
Conclusion: Esophageal tuberculosis is rare, and the diag-
ostic may be mistakenly considered as malignancy. Theoi:10.1016/j.ijid.2010.02.2179
